Medipal HoldingsMAHLY 78 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates MAHLY with a GF Score™ of 78/100 and a GF Value™ of $16.06 (Fairly Valued). The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, Medipal Holdings ranks worse than 51.69% on this metric.
The historical rank and industry rank for Medipal Holdings's FCF Margin % or its related term are showing as below:
MAHLY'
s FCF Margin % Range Over the Past 10 Years
Min: 0.08 Med: 1.01 Max: 1.42
Current: 0.92
During the past 13 years, the highest FCF Margin % of Medipal Holdings was 1.42%. The lowest was 0.08%. And the median was 1.01%.
MAHLY's FCF Margin % is ranked worse than 51.69% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs MAHLY: 0.92
Medipal Holdings FCF Margin % Related Terms
Medipal Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medipal Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medipal Holdings and its competitors. Over the past decade, Medipal Holdings' FCF Margin % has ranged from 0.08 to 1.42. According to the industry distribution chart, Medipal Holdings ranks #61 out of 118 companies in the Medical Distribution industry, placing it in the top 51.7%.
Is Medipal Holdings' FCF Margin % too high?
Medipal Holdings' current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 1.42. Based on the distribution chart, Medipal Holdings ranks #61 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #61 out of 118 companies for FCF Margin %. This places Medipal Holdings in the lower half of its industry. The industry median FCF Margin % is 1.06. Historically, Medipal Holdings' own FCF Margin % has ranged from 0.08 to 1.42 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.06, compared to a current price of $15.37 — trading 4.3% below its estimated fair value. The current FCF Margin % is 0.00%. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $15.37 is trading 4.3% below its estimated GF Value™ of $16.06.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
FCF Margin %: 0.00%
GF Value™: $16.06 vs. price of $15.37 (4.3% below fair value)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
